1. Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?

   • Rocco Capuano
   • Manuela Altieri
   • Antonio Gallo

   Original Communication Open access 28 July 2020 Pages: 743 - 750

2. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

   • Antoine Guilmot
   • Sofia Maldonado Slootjes
   • Vincent van Pesch

   Original Communication Open access 30 July 2020 Pages: 751 - 757

   

3. Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research

   • Alberto Vogrig
   • Daniele Bagatto
   • Mauro Morassi

   Letter to the Editors 01 August 2020 Pages: 758 - 761

   

4. Neurological comorbidity and severity of COVID-19

   • Alberto Romagnolo
   • Roberta Balestrino
   • Leonardo Lopiano

   Original Communication Open access 04 August 2020 Pages: 762 - 769

   

5. Neurological manifestations in 404 COVID-19 patients in Washington State

   • Pinky Agarwal
   • Sudeshna Ray
   • Brad Tyson

   Letter to the Editors 06 August 2020 Pages: 770 - 772

6. Association of history of cerebrovascular disease with severity of COVID-19

   • Timo Siepmann
   • Annahita Sedghi
   • Kristian Barlinn

   Original Communication Open access 06 August 2020 Pages: 773 - 784

   

7. Targeting blood pressure for stroke prevention: current evidence and unanswered questions

   • Yannick Béjot

   Review 26 June 2019 Pages: 785 - 795

   

8. Language impairment in progressive supranuclear palsy and corticobasal syndrome

   • Katie A. Peterson
   • Karalyn Patterson
   • James B. Rowe

   Review Open access 18 July 2019 Pages: 796 - 809

9. A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke

   • Elli Katharine Greisenegger
   • Sara Llufriu
   • Alexander Zimprich

   Original Communication Open access 26 September 2020 Pages: 810 - 816

   

10. Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study

    • Chiara Zecca
    • Giulio Disanto
    • Claudio Gobbi

    Original Communication Open access 21 October 2020 Pages: 817 - 824

    

11. Manifold learning for amyotrophic lateral sclerosis functional loss assessment

    • Vincent Grollemund
    • Gaétan Le Chat
    • Pierre-François Pradat

    Original Communication 04 September 2020 Pages: 825 - 850

    

12. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes

    • Jisun Jeong
    • Sun Woong Kim
    • Duk Hyun Sung

    Original Communication 23 October 2020 Pages: 851 - 859

    

13. Hearing loss and cognitive decline in the general population: a prospective cohort study

    • Pauline H. Croll
    • Elisabeth J. Vinke
    • M. Arfan Ikram

    Original Communication Open access 10 September 2020 Pages: 860 - 871

    

14. MRI-visible perivascular spaces as an imaging biomarker in Fabry disease

    • D. Lyndon
    • I. Davagnanam
    • D. J. Werring

    Original Communication Open access 19 October 2020 Pages: 872 - 878

    

15. Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes

    • Stéphane Mathis
    • Antoine Soulages
    • Jean-Michel Vallat

    Original Communication 10 September 2020 Pages: 879 - 890

    

16. Correction to: Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes

    • Stéphane Mathis
    • Antoine Soulages
    • Jean-Michel Vallat

    Correction 05 January 2021 Pages: 891 - 891

17. Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes

    • Stéphane Mathis
    • Antoine Soulages
    • Gwendal Le Masson

    Original Communication 11 September 2020 Pages: 892 - 902

    

18. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

    • Cynthia Comella
    • Joaquim J. Ferreira
    • Savary Om

    Original Communication Open access 16 September 2020 Pages: 903 - 912

    

19. Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

    • Cynthia Comella
    • Joaquim J. Ferreira
    • Savary Om

    Correction Open access 26 October 2020 Pages: 913 - 913

20. Assessment of Wearing Off in Parkinson’s disease using objective measurement

    • Parisa Farzanehfar
    • Holly Woodrow
    • Malcolm Horne

    Original Communication 15 September 2020 Pages: 914 - 922

    

21. Nusinersen treatment significantly improves hand grip strength, hand motor function and MRC sum scores in adult patients with spinal muscular atrophy types 3 and 4

    • Bram De Wel
    • Veerle Goosens
    • Kristl G. Claeys

    Original Communication 15 September 2020 Pages: 923 - 935

    

22. Five men with arresting and relapsing cerebral adrenoleukodystrophy

    • Aaron M. Carlson
    • Irene C. Huffnagel
    • Keith Van Haren

    Original Communication 29 September 2020 Pages: 936 - 940

    

23. Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

    • Johannes Lorscheider
    • Pascal Benkert
    • Özgür Yaldizli

    Original Communication Open access 24 September 2020 Pages: 941 - 949

    

24. An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment

    • Camilla Binz
    • Olivia Schreiber-Katz
    • Alma Osmanovic

    Original Communication Open access 07 October 2020 Pages: 950 - 962

    

25. Significance of hyposmia in isolated REM sleep behavior disorder

    • Alex Iranzo
    • Paula Marrero-González
    • Isabel Vilaseca

    Original Communication 23 September 2020 Pages: 963 - 966

    

26. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy

    • Ji-Hyun Choi
    • Heejung Kim
    • Beomseok Jeon

    Original Communication 21 September 2020 Pages: 967 - 977

    

27. Quantitative assessment of brachial plexus MRI for the diagnosis of chronic inflammatory neuropathies

    • Marieke H. J. van Rosmalen
    • H. Stephan Goedee
    • W. Ludo van der Pol

    Original Communication Open access 23 September 2020 Pages: 978 - 988

    

28. Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients

    • Olivia Samotus
    • Andrew Parrent
    • Mandar Jog

    Original Communication 03 October 2020 Pages: 989 - 996

    

29. Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study

    • Beata Lindholm
    • Christina Brogårdh
    • Peter Hagell

    Original Communication Open access 24 September 2020 Pages: 997 - 1005

30. Kinematic but not clinical measures predict falls in Parkinson-related orthostatic hypotension

    • Andrea Sturchio
    • Alok K. Dwivedi
    • Aristide Merola

    Original Communication 26 September 2020 Pages: 1006 - 1015

    

31. Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis

    • Kenichiro Taira
    • Toshiyuki Yamamoto
    • Yuji Takahashi

    Original Communication 26 September 2020 Pages: 1016 - 1024

    

32. Association between stroke lesions and videofluoroscopic findings in acute stroke patients

    • Masahiro Nakamori
    • Naohisa Hosomi
    • Hirofumi Maruyama

    Original Communication 26 September 2020 Pages: 1025 - 1035

    

33. Action fluency identifies different sex, age, global cognition, executive function and brain activation profile in non-demented patients with Parkinson’s disease

    • Noémie Auclair-Ouellet
    • Alexandru Hanganu
    • Oury Monchi

    Original Communication 30 September 2020 Pages: 1036 - 1049

    

34. Unusual electrophysiological findings in a Chinese ALS 4 family with SETX-L389S mutation: a three-year follow-up

    • Lin Lei
    • Hai Chen
    • Yuwei Da

    Original Communication 30 September 2020 Pages: 1050 - 1058

    

35. Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data

    • Anna Rada
    • Robert Birnbacher
    • Christian G. Bien

    Original Communication Open access 06 October 2020 Pages: 1059 - 1069

    

36. Cardiogenic vertigo: characteristics and proposed diagnostic criteria

    • Hyun Ah Kim
    • Jinhee Ahn
    • Kwang-Dong Choi

    Original Communication 06 October 2020 Pages: 1070 - 1075

37. Quantitative ¹H and ²³Na muscle MRI in Facioscapulohumeral muscular dystrophy patients

    • Teresa Gerhalter
    • Benjamin Marty
    • Matthias Türk

    Original Communication Open access 12 October 2020 Pages: 1076 - 1087

    

38. Sexual function, intimate relationships and Friedreich ataxia

    • Louise A. Corben
    • Mireille M. Hermans
    • Martin B. Delatycki

    Original Communication 12 October 2020 Pages: 1088 - 1095

    

39. Autoimmune cortical encephalitis in two children with anti-myelin oligodendrocyte glycoprotein (MOG) antibody

    • D. Doig
    • C. McNamara
    • W. Jan

    Original Communication 14 October 2020 Pages: 1096 - 1101

    

40. Better quality of life and less caregiver strain in young-onset Parkinson’s disease: a multicentre retrospective cohort study

    • Maarten Te Groen
    • Bastiaan R. Bloem
    • The Parkinson’s Foundation Quality Improvement Initiative investigators

    Original Communication Open access 27 October 2020 Pages: 1102 - 1109

    

41. Bilateral sequential sudden sensorineural hearing loss in protein S deficiency

    • Euyhyun Park
    • Sun-Uk Lee
    • Ji-Soo Kim

    Letter to the Editors 08 January 2021 Pages: 1110 - 1113

    

42. Bilateral vestibulopathy in anti-IgLON5 disease

    • Christoph Helmchen
    • Klaus-Peter Wandinger
    • Norbert Brüggemann

    Letter to the Editors Open access 23 January 2021 Pages: 1114 - 1116

    

43. Letter to the editors: comment on “Emerging themes in idiopathic intracranial hypertension”

    • Simona Toscano
    • Mario Zappia

    Letter to the Editors 20 January 2021 Pages: 1117 - 1118

44. CANVAS: a late onset ataxia due to biallelic intronic AAGGG expansions

    • Natalia Dominik
    • Valentina Galassi Deforie
    • Henry Houlden

    Neurological Update Open access 10 September 2020 Pages: 1119 - 1126

    

45. Deep brain stimulation for Parkinson’s disease: an update on efficacy and an emerging alternative

    • Dafydd Morgan
    • Wilson Fung

    Journal club 15 February 2021 Pages: 1127 - 1129

46. John Hilton (1805–1878)

    • Andrzej Grzybowski
    • Monika Zamachowska

    Pioneers in Neurology Open access 02 April 2020 Pages: 1130 - 1132